市場調查報告書
商品編碼
1084380
生物晶片的世界市場趨勢、預測 (2022年~2028年):各產品類型、技術、用途、地區Biochips Market By Product Type, Technology, Application and by Geography - Global Trends and Forecast, 2022 - 2028 |
由於為削減時間、成本的實驗室小型化,及製造商提供廣泛的產品系列以對應廣泛的用途等要素,促進生物晶片市場成長。
本報告提供全球生物晶片的市場調查,市場定義和概要,市場成長的各種影響因素分析,市場規模的變化、預測,各種區分、各地區/主要國家的明細,競爭環境,主要企業簡介等彙整資訊。
市場佔有率分析
市場佔有率分析
Biochip technology holds applications in areas such as diagnosis of infectious diseases, respiratory diseases, cancer, and for personalized treatment. Microarray or biochip technology could prove beneficial, as prevalence of these diseases is increasing worldwide. Complexity of the technology, necessary resources in terms of manufacturing, and research and development of these products reflects in terms of high prices. Although the product helps in reducing costs incurred in laboratory methods, the biochip technology itself is still costly. Manufacturers and universities are focused on improving technology of the biochips in order to increase the precision of the results while lowering the costs and time. For instance, researchers from Stanford University School of Medicine had developed a method to produce cheap and reusable diagnostic lab-on-a-chip with the help of an inkjet printer, which was worth 1 cent per chip, in 2017.
Miniaturization of laboratory facilities to save time and costs and extensive product portfolios with wide number of applications of biochips offered by manufacturer’s drives growth of biochips market. Manufacturers offer technologically advanced products in order to minimize time and costs, and improve research outcomes. For instance, Micralyne, Inc. launched Silicon MicraFluidics technology, a line of standardized microfluidic process technologies, which enabled rapid design and deployment of microfluidic-based products in February 2018. Technological advancements in biochips platform, ongoing research and development to widen the applications, and advantages offered by biochip technologies over conventional laboratory with respect to time, costs, and ease of use is expected to fuel growth of the market.
This report provides in-depth analysis of biochips market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global biochips market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key companies covered as a part of this study include Randox Laboratories, Fluidigm Corporation, Abbott Laboratories, Agilent Technologies, Inc., ThermoFisher Scientific, Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., and PerkinElmer, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global biochips market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the biochips market
Global Biochips Market, By Product Type:
DNA Chips
Protein Chips
Lab-on-a-Chip
Others (Cell Arrays & Tissue Arrays)
Global Biochips Market, By Technology:
Microfluidics
Microarray
Global Biochips Market, By Application:
Genomics
Proteomics
Drug Discovery & Development
In-Vitro Diagnostics
Global Biochips Market, By Geography:
North America
By Product Type:
DNA Chips
Protein Chips
Lab-on-a-Chip
Others (Cell Arrays & Tissue Arrays)
By Technology:
Microfluidics
Microarray
By Application:
Genomics
Proteomics
Drug Discovery & Development
In-Vitro Diagnostics
By Country:
U.S.
Canada
Europe
By Product Type:
DNA Chips
Protein Chips
Lab-on-a-Chip
Others (Cell Arrays & Tissue Arrays)
By Technology:
Microfluidics
Microarray
By Application:
Genomics
Proteomics
Drug Discovery & Development
In-Vitro Diagnostics
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type:
DNA Chips
Protein Chips
Lab-on-a-Chip
Others (Cell Arrays & Tissue Arrays)
By Technology:
Microfluidics
Microarray
By Application:
Genomics
Proteomics
Drug Discovery & Development
In-Vitro Diagnostics
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Product Type:
DNA Chips
Protein Chips
Lab-on-a-Chip
Others (Cell Arrays & Tissue Arrays)
By Technology:
Microfluidics
Microarray
By Application:
Genomics
Proteomics
Drug Discovery & Development
In-Vitro Diagnostics
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
By Product Type:
DNA Chips
Protein Chips
Lab-on-a-Chip
Others (Cell Arrays & Tissue Arrays)
By Technology:
Microfluidics
Microarray
By Application:
Genomics
Proteomics
Drug Discovery & Development
In-Vitro Diagnostics
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
DNA Chips
Protein Chips
Lab-on-a-Chip
Others (Cell Arrays & Tissue Arrays)
By Technology:
Microfluidics
Microarray
By Application:
Genomics
Proteomics
Drug Discovery & Development
In-Vitro Diagnostics
By Country:
Central Africa
South Africa
North Africa
Company Profiles
Randox Laboratories*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Fluidigm Corporation
Abbott Laboratories
Agilent Technologies, Inc.
ThermoFisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
Illumina, Inc.
PerkinElmer, Inc.
“*” marked represents similar segmentation in other categories in the respective section.
§ Market Definition and Scope
§ Market Snippet, By Product Type
§ Market Snippet, By Technology
§ Market Snippet, By Application
§ Market Snippet, By Region
§ Drivers
§ Restraints
§ Market Opportunities
§ Market Share Analysis, 2022 and 2028 (%)
§ Y-o-Y Growth Analysis, 2017 - 2028
§ Segment Trends
§ Introduction
§ Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
§ Introduction
§ Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
§ Introduction
§ Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
§ Introduction
§ Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
§ Market Share Analysis, 2022 and 2028 (%)
§ Y-o-Y Growth Analysis, 2017 - 2028
§ Segment Trends
§ Introduction
§ Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
§ Introduction
§ Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
§ Market Share Analysis, 2022 and 2028 (%)
§ Y-o-Y Growth Analysis, 2017 - 2028
§ Segment Trends
§ Introduction
§ Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
§ Introduction
§ Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
§ Introduction
§ Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
§ Introduction
§ Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
§ Market Share Analysis, By Region, 2022 and 2028 (%)
§ Y-o-Y Growth Analysis, For Regions, 2017 - 2028
§ Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
§ Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
§ Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
§ Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
§ U.S.
§ Canada
§ Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
§ Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
§ Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
§ Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
§ U.K.
§ Germany
§ Italy
§ France
§ Spain
§ Russia
§ Rest of Europe
§ Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
§ Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
§ Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
§ Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
§ China
§ India
§ Japan
§ ASEAN
§ Australia
§ South Korea
§ Rest of APAC
§ Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
§ Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
§ Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
§ Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
§ Brazil
§ Mexico
§ Argentina
§ Rest of Latin America
§ Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
§ Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
§ Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
§ Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
§ Central Africa
§ South Africa
§ North Africa
§ Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
§ Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
§ Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
§ Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
§ GCC
§ Israel
§ Rest of Middle East
§ Randox Laboratories
§ Company Overview
§ Product Portfolio
§ Key Developments
§ Financial Performance
§ Strategies
§ Fluidigm Corporation
§ Company Overview
§ Product Portfolio
§ Key Developments
§ Financial Performance
§ Strategies
§ Abbott Laboratories
§ Company Overview
§ Product Portfolio
§ Key Developments
§ Financial Performance
§ Strategies
§ Agilent Technologies, Inc.
§ Company Overview
§ Product Portfolio
§ Key Developments
§ Financial Performance
§ Strategies
§ ThermoFisher Scientific, Inc.
§ Company Overview
§ Product Portfolio
§ Key Developments
§ Financial Performance
§ Strategies
§ Bio-Rad Laboratories, Inc.
§ Company Overview
§ Product Portfolio
§ Key Developments
§ Financial Performance
§ Strategies
§ Illumina, Inc.
§ Company Overview
§ Product Portfolio
§ Key Developments
§ Financial Performance
§ Strategies
§ PerkinElmer, Inc.
§ Company Overview
§ Product Portfolio
§ Key Developments
§ Financial Performance
§ Strategies